논문 및 학회자료
|
Safety evaluation of FM101, an A3 adenosine receptor modulator, in rat, for developing as therapeutics of glaucoma and hepatitis. EXCLI Journal. 2020
Admin │ 2021-03-07 HIT 428 |
|---|
| 이전글 | 이전글이 없습니다. |
|---|---|
| 다음글 | LJ-2698, an Adenosine A3 Receptor Antagonist, Alleviates Elastase-Induced Pulmon... |